Back to results
US 2023/0398208 A1Published application
SARS-CoV-2 VACCINES AND USES THEREOF
AssigneeFred Hutchinson Cancer Center
InventorsJason Price, James Olson, Colin E. Correnti, Barry L. Stoddard
Life of this patent
Estimating the term…
Abstract
SARS-CoV-2 vaccines are described herein. The SARS-CoV-2 vaccine antigens can be presented on a circular tandem repeat protein (cTRP) scaffold as trimers or tetramers. The vaccines can be used to treat and/or reduce the risk of SARS-CoV-2 infection and to treat and/or reduce the risk of side effects associated with SARS-CoV-2 infection, such as SARS-CoV-2-related symptoms, syndromes, and complications.
Claims18
A SARS-CoV-2 vaccine comprising the sequence as set forth in SEQ ID NO:
- 4 or 9 or a sequence having at least 98% sequence identity to the sequence as set forth in SEQ ID NO:
- 4 or 9.
6-40. (canceled)
48-63. (canceled)
Dependencies are inferred from the claim text.